Novel Opportunities to Use Radiation Therapy with Immune Checkpoint Inhibitors for Melanoma Management
- 1 July 2017
- journal article
- review article
- Published by Elsevier in Surgical Oncology Clinics of North America
- Vol. 26 (3) , 515-529
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Immunologic Correlates of the Abscopal Effect in a Patient with MelanomaNew England Journal of Medicine, 2012
- Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain MetastasesJournal of Clinical Oncology, 2012
- The convergence of radiation and immunogenic cell death signaling pathwaysFrontiers in Oncology, 2012
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 AntibodyClinical Cancer Research, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Immunological aspects of cancer chemotherapyNature Reviews Immunology, 2008
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapyJournal of Experimental Medicine, 2006
- Checkpoint Blockade in Cancer Immunotherapy2006